secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xenon Pharmaceuticals Inc. (XENE)
CIK:        0001582313
Form:       8-K
Filed at:   2025-12-01T23:59:59+00:00
Accession:  0001193125-25-303862
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xenon Pharma amends inducement plan, increases share reserve to 900,000
-----------------------------------------------------------------------

- Amended 2025 Inducement Plan on Nov 24, 2025, increasing share reserve from 775,000 to 900,000 common shares.
- Plan is exclusively for inducing new employees or rehires after a bona fide interruption of employment.
- No shareholder approval sought under Nasdaq Listing Rule 5635(c)(4); plan meets inducement grant rules.
- Awards include nonstatutory stock options, SARs, restricted stock units, restricted stock, and performance awards.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1582313/000119312525303862/0001193125-25-303862-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1582313/000119312525303862/xene-20251124.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-303862

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer